1. Home
  2. LCTX vs NKSH Comparison

LCTX vs NKSH Comparison

Compare LCTX & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$0.79

Market Cap

251.4M

Sector

Health Care

ML Signal

N/A

Logo National Bankshares Inc.

NKSH

National Bankshares Inc.

N/A

Current Price

$37.07

Market Cap

256.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LCTX
NKSH
Founded
1990
1891
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
251.4M
256.1M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
LCTX
NKSH
Price
$0.79
$37.07
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $5.50
N/A
AVG Volume (30 Days)
★ 2.1M
14.6K
Earning Date
11-12-2026
10-22-2026
Dividend Yield
N/A
★ 4.10%
EPS Growth
N/A
★ 100.81
EPS
N/A
★ 2.43
Revenue
★ $14,556,000.00
$8,176,000.00
Revenue This Year
$4.38
N/A
Revenue Next Year
$10.80
N/A
P/E Ratio
★ N/A
$15.17
Revenue Growth
★ 53.24
9.39
52 Week Low
$0.77
$28.55
52 Week High
$1.99
$45.99

Technical Indicators

Market Signals
Indicator
LCTX
NKSH
Relative Strength Index (RSI) 34.81 27.39
Support Level N/A $34.71
Resistance Level $1.16 $38.30
Average True Range (ATR) 0.08 1.07
MACD -0.03 -0.26
Stochastic Oscillator 2.86 7.98

Price Performance

Historical Comparison
LCTX
NKSH

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

About NKSH National Bankshares Inc.

National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.

Share on Social Networks: